Location History:
- Hamden, CT (US) (2007)
- North Haven, CT (US) (2008 - 2010)
Company Filing History:
Years Active: 2007-2010
Title: Xiang Jun J Jiang: Innovator in Anti-Migraine Therapeutics
Introduction
Xiang Jun J Jiang is a notable inventor based in North Haven, CT (US), recognized for his contributions to the field of pharmaceuticals, particularly in the development of anti-migraine therapies. With a total of four patents to his name, Jiang has made significant strides in addressing complex medical conditions through innovative compounds.
Latest Patents
Jiang's latest patents focus on anti-migraine spirocycles, which are designed as antagonists of calcitonin gene-related peptide receptors (CGRP-receptors). These compounds are part of pharmaceutical compositions aimed at treating various conditions, including neurogenic vasodilation, neurogenic inflammation, migraines, and other headaches. His inventions also target thermal injury, circulatory shock, flushing associated with menopause, and airway inflammatory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The therapeutic potential of these compounds highlights Jiang's commitment to advancing medical science.
Career Highlights
Throughout his career, Jiang has been associated with Bristol-Myers Squibb Company, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work has not only led to the creation of effective treatments but has also positioned him as a key figure in the innovation of therapeutic solutions.
Collaborations
Jiang has collaborated with esteemed colleagues, including Prasad V Chaturvedula and Gene Michael Dubowchik, to further enhance the research and development of his patented compounds. These collaborations have played a crucial role in refining the therapeutic applications of his inventions.
Conclusion
Xiang Jun J Jiang's innovative work in the field of anti-migraine therapeutics exemplifies the impact of dedicated research and collaboration in advancing healthcare solutions. His contributions continue to pave the way for effective treatments that address significant medical challenges.